Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ProCyte begins shipping Iamin peptide-copper wound care gel July 1.

This article was originally published in The Gray Sheet

Executive Summary

PROCYTE BEGINS SHIPPING IAMIN HYDROGEL WOUND DRESSING on July 1, the company says. Procyte made its first shipment of the copper-containing wound dressing to Choice Medical, a Seattle-based home health products distributor. Iamin, which gained 510(k) clearance in February, is intended to treat diabetic, venous or mixed etiology leg ulcers, pressure sores, first- and second-degree burns, donor sites, and surgical wounds. Procyte began shipments after ramping up production at its Redmond, Washington facility.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006326

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel